Scientists at Johns Hopkins say that an experimental antibody drug appears to prevent and reverse the onset of type 1 diabetes in mice—and often lengthen their lives. The drug called mAb43 is unique, according to the researchers, because it targets insulin-making beta cells in the pancreas directly and is designed to shield those cells from […]

The post Experimental Type 1 Diabetes Drug Shields Pancreas Cells from the Usual Crippling Immune System Attack appeared first on Good News Network.



from Good News Network https://ift.tt/Fr68uZI